Home
Conditions
Paraganglioma

Clinical trial condition

Paraganglioma

Explore clinical trials studying Paraganglioma. Study availability and eligibility vary by location and protocol.

70 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Paraganglioma trial results

Completed

Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

NCT04400474

Conditions: Adenocarcinoma, Anaplastic Thyroid Cancer, Carcinoma, +11 more
Locations: Hospital Germans Trias i Pujol - ICO Badalona Badalona, Barcelona, Spain

Hospital Duran i Reynals - ICO L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

Hospital General Universitario Elche Alicante, Spain

Hospital Universitari Vall d'Hebron Barcelona, Spain

View all 15 locations

View Trial Details

Completed

Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics

NCT06669481

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Peking union medical college hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma

NCT00843037

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada

Hôpital Notre-Dame du CHUM Montreal, Quebec, Canada

University Medical Centre Groningen Groningen, Netherlands

View Trial Details

Completed

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

NCT04860700

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Neoplasm Metastasis, +14 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Preoperative Alpha Blockade for Pheochromocytoma

NCT03176693

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: University of California, Los angeles Los Angeles, California, United States

View Trial Details

Completed

Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey

NCT05942482

Conditions: Head and Neck Paraganglioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Pamukkale University Denizli, Turkey (Türkiye)

View Trial Details

Completed

The Efficacy and Safety of Temozolomide in Patients With MPPGL

NCT05858177

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation

NCT02186678

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Assistance Publique Hopitaux de Marseille Marseille, France

View Trial Details

Completed

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

NCT00442533

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations: Excel Diagnostic Imaging Clinics Houston, Texas, United States

St. Lukes Episcopal Hospital Houston, Texas, United States

View Trial Details

Completed

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

NCT01371201

Conditions: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL), Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Institut de Cancérologie Gustave roussy Villejuif, France

Universitätsklinikum Würzburg Würburg, Germany

University of Padova Padova, Italy

Radboud University Nijmegen Medical Centre Nijmegen, GA, Netherlands

View Trial Details

Paraganglioma

Paraganglioma trial results

Related conditions